The global dry eye market is expected to reach $7.78b by 2025 (Transparency Market Research). The dry eye market includes pharmaceuticals, diagnostics, surgery and new devices (profiled below). Key drivers include: the aging population; the rising prevalence of diseases like diabetes and rheumatoid arthritis that can give rise to dry eyes;...
Read More
Medicare ACOs began in 2012 and have enrolled more than 10 million beneficiaries so far. If they provide care for less than certain cost targets — while meeting quality of care standards — then they get to share in any of the savings. Commercial insurers and Medicaid have also adopted ACOs in the past decade. About 82% of the 561 Medicare ACOs...
Read More
The retail giant plans to start a Seattle-based clinic, which will serve a small group of employees at first. The program will then be expanded in early 2019, as part of an ongoing quest to reduce health care costs and cut red tape. Apple also started clinics, initially to serve Apple’s employees in Santa Clara County. Recently, Amazon teamed up...
Read More
Emergent BioSolutions, Inc., a $560.8m specialty pharmaceutical company focused on public health threats, is buying PaxVax, Inc., a PE- backed company focuses on specialty vaccines against existing and emerging infectious diseases. The deal expands Emergent's specialty vaccine platform. PaxVax's main product include Vivotif, the only oral...
Read More
President Trump’s tariffs on Chinese imports could cost American medical device makers more than $1.5b annually, according to some estimates. MRIs, CT scanners, pacemakers, sonograms and other imaging components were all included in the list of items subject to the 25% tariffs that went into effect on June 6. Also included are a variety of...
Read More